No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke

BACKGROUND: Dabigatran etexilate (DE) is a new oral direct thrombin inhibitor. Clinical trials point towards a favourable risk-to-benefit profile of DE compared to warfarin. In this study, we evaluated whether hemorrhagic transformation (HT) occurs after experimental stroke under DE treatment as we...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bohmann, Ferdinand, Mirceska, Ana, Pfeilschifter, Josef, Lindhoff-Last, Edelgard, Steinmetz, Helmuth, Foerch, Christian, Pfeilschifter, Waltraud
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2012
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3404053/
https://ncbi.nlm.nih.gov/pubmed/22911709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0040804
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items